- Home
- Publications
- Publication Search
- Publication Details
Title
Role of p38 MAP kinase in cancer stem cells and metastasis
Authors
Keywords
-
Journal
ONCOGENE
Volume 41, Issue 23, Pages 3177-3185
Publisher
Springer Science and Business Media LLC
Online
2022-05-02
DOI
10.1038/s41388-022-02329-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Survival analysis in breast cancer using proteomic data from four independent datasets
- (2021) Ágnes Ősz et al. Scientific Reports
- p85β alters response to EGFR inhibitor in ovarian cancer through p38 MAPK-mediated regulation of DNA repair
- (2021) Victor CY Mak et al. NEOPLASIA
- AMPK promotes antitumor immunity by downregulating PD-1 in regulatory T cells via the HMGCR/p38 signaling pathway
- (2021) Ram Hari Pokhrel et al. Molecular Cancer
- The p38 Pathway: From Biology to Cancer Therapy
- (2020) Adrián Martínez-Limón et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Bone marrow stromal cells induce an ALDH+ stem cell-like phenotype and enhance therapy resistance in AML through a TGF-β-p38-ALDH2 pathway
- (2020) Bin Yuan et al. PLoS One
- Conversion of Stem Cells to Cancer Stem Cells: Undercurrent of Cancer Initiation
- (2019) Said Afify et al. Cancers
- Tobacco smoke induced hepatic cancer stem cell-like properties through IL-33/p38 pathway
- (2019) Chunfeng Xie et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The Role of Epithelial-to-Mesenchymal Plasticity in Ovarian Cancer Progression and Therapy Resistance
- (2019) Nele Loret et al. Cancers
- Gemcitabine‐induced epithelial‐mesenchymal transition‐like changes sustain chemoresistance of pancreatic cancer cells of mesenchymal‐like phenotype
- (2019) Mehdi El Amrani et al. MOLECULAR CARCINOGENESIS
- A randomized, double-blind, placebo-controlled phase 1b/2 study of ralimetinib, a p38 MAPK inhibitor, plus gemcitabine and carboplatin versus gemcitabine and carboplatin for women with recurrent platinum-sensitive ovarian cancer
- (2019) Ignace Vergote et al. GYNECOLOGIC ONCOLOGY
- The Clinical Impact of Cancer Stem Cells
- (2019) Justin Lathia et al. ONCOLOGIST
- Bone secreted factors induce cellular quiescence in prostate cancer cells
- (2019) Li-Yuan Yu-Lee et al. Scientific Reports
- KLF4 functions as an oncogene in promoting cancer stem cell-like characteristics in osteosarcoma cells
- (2018) Xiao-tian Qi et al. ACTA PHARMACOLOGICA SINICA
- Targeting p38α Increases DNA Damage, Chromosome Instability, and the Anti-tumoral Response to Taxanes in Breast Cancer Cells
- (2018) Begoña Cánovas et al. CANCER CELL
- Reciprocal Regulation of DUSP9 and DUSP16 Expression by HIF-1 Controls ERK and p38 MAP Kinase Activity and Mediates Chemotherapy-Induced Breast Cancer Stem Cell Enrichment
- (2018) Haiquan Lu et al. CANCER RESEARCH
- Role of p38 MAPK in disease relapse and therapeutic resistance by maintenance of cancer stem cells in head and neck squamous cell carcinoma
- (2018) Shomereeta Roy et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- NRP-1 interacts with GIPC1 and α6/β4-integrins to increase YAP1/∆Np63α-dependent epidermal cancer stem cell survival
- (2018) Daniel Grun et al. ONCOGENE
- Diagnostic Significance of p38 Isoforms (p38α, p38β, p38γ, p38δ) in Head and Neck Squamous Cell Carcinoma: Comparative Serum Level Evaluation and Design of Novel Peptide Inhibitor Targeting the Same
- (2018) Vishal Sahu et al. Cancer Research and Treatment
- Marine sponge-derived smenospongine preferentially eliminates breast cancer stem-like cells via p38/AMPKα pathways
- (2018) Jie Tang et al. Cancer Medicine
- p38 MAPK pathway and its interaction with TRF2 in cisplatin induced chemotherapeutic response in head and neck cancer
- (2018) Shomereeta Roy et al. Oncogenesis
- Role of p38γ MAPK in regulation of EMT and cancer stem cells
- (2018) Mei Xu et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas
- (2018) Mohit Kumar Jolly et al. PHARMACOLOGY & THERAPEUTICS
- A Unique Nonsaccharide Mimetic of Heparin Hexasaccharide Inhibits Colon Cancer Stem Cells via p38 MAP Kinase Activation
- (2018) Rio S. Boothello et al. MOLECULAR CANCER THERAPEUTICS
- Drug Resistance Driven by Cancer Stem Cells and Their Niche
- (2017) Marta Prieto-Vila et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- p38 MAPK inhibits autophagy and promotes microglial inflammatory responses by phosphorylating ULK1
- (2017) Yingli He et al. JOURNAL OF CELL BIOLOGY
- EMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression
- (2017) Davide Pradella et al. Molecular Cancer
- The crosstalk between p38 and Akt signaling pathways orchestrates EMT by regulating SATB2 expression in NSCLC cells
- (2017) Hakan Kucuksayan et al. TUMOR BIOLOGY
- Inactivation of p38 MAPK contributes to stem cell-like properties of non-small cell lung cancer
- (2017) Yan Fang et al. Oncotarget
- The p38 signaling pathway mediates quiescence of glioma stem cells by regulating epidermal growth factor receptor trafficking
- (2017) Akio Soeda et al. Oncotarget
- UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
- (2017) Darshan S. Chandrashekar et al. NEOPLASIA
- Loss of Functionally Redundant p38 Isoforms in T Cells Enhances Regulatory T Cell Induction
- (2016) Morisada Hayakawa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Notch1-MAPK Signaling Axis Regulates CD133 + Cancer Stem Cell-Mediated Melanoma Growth and Angiogenesis
- (2016) Dhiraj Kumar et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- ErbB2 and p38γ MAPK mediate alcohol-induced increase in breast cancer stem cells and metastasis
- (2016) Mei Xu et al. Molecular Cancer
- Inhibition of FOXC2 restores epithelial phenotype and drug sensitivity in prostate cancer cells with stem-cell properties
- (2016) A N Paranjape et al. ONCOGENE
- Phosphorylation of serine 367 of FOXC2 by p38 regulates ZEB1 and breast cancer metastasis, without impacting primary tumor growth
- (2016) S J Werden et al. ONCOGENE
- p38 MAPK mediates epithelial-mesenchymal transition by regulating p38IP and Snail in head and neck squamous cell carcinoma
- (2016) Yuan Lin et al. ORAL ONCOLOGY
- Heparan sulfate hexasaccharide selectively inhibits cancer stem cells self-renewal by activating p38 MAP kinase
- (2016) Nirmita J. Patel et al. Oncotarget
- p38γ MAPK Is a Therapeutic Target for Triple-Negative Breast Cancer by Stimulation of Cancer Stem-Like Cell Expansion
- (2015) Xiaomei Qi et al. STEM CELLS
- The Cancer Stem Cell Marker Aldehyde Dehydrogenase Is Required to Maintain a Drug-Tolerant Tumor Cell Subpopulation
- (2014) D. Raha et al. CANCER RESEARCH
- Integrin αvβ3 Drives Slug Activation and Stemness in the Pregnant and Neoplastic Mammary Gland
- (2014) Jay S. Desgrosellier et al. DEVELOPMENTAL CELL
- Metformin combined with p38 MAPK inhibitor improves cisplatin sensitivity in cisplatin-resistant ovarian cancer
- (2014) YA XIE et al. Molecular Medicine Reports
- Inhibition of the p38 MAPK pathway sensitizes human gastric cells to doxorubicin treatment in vitro and in vivo
- (2014) WEI TAN et al. Molecular Medicine Reports
- An integrin β3–KRAS–RalB complex drives tumour stemness and resistance to EGFR inhibition
- (2014) Laetitia Seguin et al. NATURE CELL BIOLOGY
- Inhibition of p38 MAPK sensitizes tumour cells to cisplatin-induced apoptosis mediated by reactive oxygen species and JNK
- (2013) Lorena Pereira et al. EMBO Molecular Medicine
- Inhibition of p38 mitogen-activated protein kinase alters microRNA expression and reverses epithelial-to-mesenchymal transition
- (2013) JAMES W. ANTOON et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- TGF-β2 dictates disseminated tumour cell fate in target organs through TGF-β-RIII and p38α/β signalling
- (2013) Paloma Bragado et al. NATURE CELL BIOLOGY
- Cancer stem cells: The challenges ahead
- (2013) Jan Paul Medema NATURE CELL BIOLOGY
- Interleukin-17 produced by tumor microenvironment promotes self-renewal of CD133+ cancer stem-like cells in ovarian cancer
- (2013) T Xiang et al. ONCOGENE
- Mesenchymal phenotype after chemotherapy is associated with chemoresistance and poor clinical outcome in esophageal cancer
- (2013) JOHJI HARA et al. ONCOLOGY REPORTS
- BIRB796, the Inhibitor of p38 Mitogen-Activated Protein Kinase, Enhances the Efficacy of Chemotherapeutic Agents in ABCB1 Overexpression Cells
- (2013) Dan He et al. PLoS One
- P38/NF-κB/Snail Pathway Is Involved in Caffeic Acid-Induced Inhibition of Cancer Stem Cells-Like Properties and Migratory Capacity in Malignant Human Keratinocyte
- (2013) Ye Yang et al. PLoS One
- p38MAPK inhibition: a new combined approach to reduce neuroblastoma resistance under etoposide treatment
- (2013) B Marengo et al. Cell Death & Disease
- Mesenchymal and stemness circulating tumor cells in early breast cancer diagnosis
- (2012) Guislaine Barrière et al. BMC CANCER
- The stress-activated protein kinases p38α/β and JNK1/2 cooperate with Chk1 to inhibit mitotic entry upon DNA replication arrest
- (2012) Alba Llopis et al. CELL CYCLE
- Gadd45γ and Map3k4 Interactions Regulate Mouse Testis Determination via p38 MAPK-Mediated Control of Sry Expression
- (2012) Nick Warr et al. DEVELOPMENTAL CELL
- Cancer stem cells
- (2012) Zuoren Yu et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- A restricted cell population propagates glioblastoma growth after chemotherapy
- (2012) Jian Chen et al. NATURE
- Survival of Cancer Stem Cells under Hypoxia and Serum Depletion via Decrease in PP2A Activity and Activation of p38-MAPKAPK2-Hsp27
- (2012) Shih-Pei Lin et al. PLoS One
- Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients
- (2011) Cristina Raimondi et al. BREAST CANCER RESEARCH AND TREATMENT
- DNA repair: the culprit for tumor-initiating cell survival?
- (2011) Lesley A. Mathews et al. CANCER AND METASTASIS REVIEWS
- Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone
- (2011) Aya Kobayashi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin–TGFβ signaling
- (2011) P-K Lo et al. ONCOGENE
- Genetic analysis of specific and redundant roles for p38 and p38 MAPKs during mouse development
- (2011) I. del Barco Barrantes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting the p38 MAPK Pathway Inhibits Irinotecan Resistance in Colon Adenocarcinoma
- (2010) S. Paillas et al. CANCER RESEARCH
- Mitogen-Activated Protein Kinases Promote WNT/ -Catenin Signaling via Phosphorylation of LRP6
- (2010) I. Cervenka et al. MOLECULAR AND CELLULAR BIOLOGY
- C-X-C receptor type 4 promotes metastasis by activating p38 mitogen-activated protein kinase in myeloid differentiation antigen (Gr-1)-positive cells
- (2010) S. Hiratsuka et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Association of Breast Cancer Stem Cells Identified by Aldehyde Dehydrogenase 1 Expression with Resistance to Sequential Paclitaxel and Epirubicin-Based Chemotherapy for Breast Cancers
- (2009) T. Tanei et al. CLINICAL CANCER RESEARCH
- Aldehyde Dehydrogenase 1 Is a Tumor Stem Cell-Associated Marker in Lung Cancer
- (2009) F. Jiang et al. MOLECULAR CANCER RESEARCH
- The Increasing Complexity of the Cancer Stem Cell Paradigm
- (2009) J. M. Rosen et al. SCIENCE
- Increased p38-MAPK is responsible for chemotherapy resistance in human gastric cancer cells
- (2008) Xianling Guo et al. BMC CANCER
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started